News & Updates

The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.

Treatment with eldecalcitol, an active vitamin D analogue, does not result in a significant reduction in diabetes incidence and has failed to improve the rate of regression to normoglycaemia relative to placebo among patients with impaired glucose tolerance at high risk for type 2 diabetes (T2D), results of a study have shown.

High-intensity exercise induces comparable cardiac responses in type 2 diabetes (T2D) patients vs healthy individuals, a recent study has found.

Among diabetes mellitus patients with COVID-19, the presence of diabetic retinopathy is independently associated with poor COVID-19 prognosis, as shown in a study.

Only a minority of patients are considered fully recovered 1 year after being discharged from hospital due to COVID-19, with women and obese individuals at increased risk of long COVID, according to results of the prospective PHOSP-COVID* study presented at ECCMID 2022 and published in The Lancet.

A recent study has demonstrated the importance of gastrointestinal (GI) symptoms as a clinical morbidity and that these symptoms are associated with increasing age, duration of type 1 diabetes (T1D), haemoglobin A1c (HbA1c), and microvascular complications, but not with autoimmune comorbidities including coeliac disease (CD).

Young, premenopausal women with long or irregular menstrual cycles are at an increased risk of both prevalent and incident nonalcoholic fatty liver disease (NAFLD), reveals a study.